COVID-19 and Diabetes: The Importance of Controlling RAGE

COVID-19 and Diabetes: The Importance of Controlling RAGE

Bibliographic Details
Main Authors:	Ernestina M. De Francesco, Veronica Vella, Antonino Belfiore
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Endocrinology
Subjects:	COVID-19 diabetes RAGE (receptor for advanced glycation end products) HMGB-1 (high mobility group box 1) pneumonia coagulation disorders
Online Access:	https://www.frontiersin.org/article/10.3389/fendo.2020.00526/full

Similar Items

RAGE Signaling in Melanoma Tumors
by: Olamide T. Olaoba, et al.
Published: (2020-11-01)

The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin
by: Cristian Zenerino, et al.
Published: (2017-11-01)

HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets
by: Petra Tesarova, et al.
Published: (2016-03-01)

Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies
by: Lorenzi, Rodrigo
Published: (2013)

Understanding the Role of the Receptor for Advanced Glycation End-Products (Rage) in Pancreatic Cancer
by: Swami, Priyanka
Published: (2019)

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
by: Liuyang Ren, et al.
Published: (2021-01-01)

Thrombomodulin Modulates Dendritic Cells via Both Antagonism of High Mobility Group Protein B1 and an Independent Mechanism
by: Masaaki Toda, et al.
Published: (2014-01-01)

Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
by: Eiichiro Tanaka, et al.
Published: (2013-09-01)

Plausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure
by: Joshua B. Lewis, et al.
Published: (2017-03-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
by: Ali H. El-Far, et al.
Published: (2020-05-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes
by: Yifan Xiao, et al.
Published: (2021-04-01)

The Immune Tolerance Role of the HMGB1-RAGE Axis
by: Haruki Watanabe, et al.
Published: (2021-03-01)

S100B Impairs Oligodendrogenesis and Myelin Repair Following Demyelination Through RAGE Engagement
by: Gisela Santos, et al.
Published: (2020-09-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury
by: Lei Mi, et al.
Published: (2019-08-01)

Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
by: Deepika Garg, et al.
Published: (2015-12-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin
by: Adriana Machado-Lima, et al.
Published: (2020-10-01)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
by: Eva O. Melin, et al.
Published: (2020-10-01)

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
by: Nordin M. J. Hanssen, et al.
Published: (2020-09-01)

From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis
by: Stefania Mardente, et al.
Published: (2018-01-01)

RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma
by: Jaisy Arikkatt, et al.
Published: (2017-01-01)

Study of sRAGE, HMGB1, AGE, and S100A8/A9 Concentrations in Plasma and in Serum-Extracted Extracellular Vesicles of Pregnant Women With Preterm Premature Rupture of Membranes
by: Damien Bouvier, et al.
Published: (2020-06-01)

Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
by: Agnieszka Bronowicka-Szydełko, et al.
Published: (2021-09-01)

Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells
by: Won Seok Yang, et al.
Published: (2018-11-01)

Receptor of advanced glycation end products in childhood asthma exacerbation
by: Adel Salah Bediwy, et al.
Published: (2016-01-01)

Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
by: Alexandra Eichhorst, et al.
Published: (2019-07-01)

RAGE in the pathophysiology of skeletal muscle
by: Francesca Riuzzi, et al.
Published: (2018-12-01)

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
by: Yanyan Kong, et al.
Published: (2020-07-01)

Mechanism of HMGB1–RAGE in Kawasaki disease with coronary artery injury
by: Biying Qian, et al.
Published: (2020-03-01)

The plasma level of soluble receptor for advanced glycation end products in systemic lupus erythematosus patients and its relation to disease activity
by: Anna Nashaat Abou-Raya, et al.
Published: (2016-06-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

HMGB1/RAGE axis mediates stress-induced RVLM neuroinflammation in mice via impairing mitophagy flux in microglia
by: Shutian Zhang, et al.
Published: (2020-01-01)

Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
by: Strohbuecker L, et al.
Published: (2019-02-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
by: Juhyun Song, et al.
Published: (2014-07-01)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019-04-01)